… Immune checkpoint inhibitors (ICIs) represent a major advance in the treatment of cancer.
Although clinical … In this descriptive observational analysis, we aimed to describe the clinical …

… tolerized through immune checkpoints. Treatment with immune checkpoint inhibitors in this
… Immune checkpoint inhibitor treatment in this environment will lead to a cross-reactivity irAE …

… led to treatment-related deaths in early clinical trials. This review summarizes the … checkpoint
inhibitors and discusses the prognostic significance of tumor type. The wide range of clinical…

… Immune checkpoint inhibition with monoclonal antibodies is … of action of checkpoint
inhibitors and although immune-… an overview of the clinical features, pathological findings and …

… date, we provide several key insights into the clinical features and outcomes of ICPi-AKI. First,
… 7 and others 8 , 9 , 12 on the clinical features of ICPi-AKI, including the variable and often …

… Immune checkpoint inhibitors (ICIs) have been changing the … Therefore, inhibition of immune
checkpoint can lead to the … PD-1/PD-L1 inhibitors. Treatment with systemic steroids is the …

… Analysis of ATB use and clinic features In this study, we performed a meta-analysis between
ATB use and clinic features, including ECOG score (≤), PD-L1 expression (<1%), non-small…

… Immune checkpoint inhibitors (ICIs) have improved the … This study aimed to reveal the
clinical features of the hepatic … We also describe the histological findings and clinical courses of …

Introduction Immune checkpoint inhibitors (ICIs) are effective in treating several cancers;
however, acute kidney injury (AKI) can occur as part as an immune-related adverse event (iRAE…

… Immune checkpoint inhibitors (ICIs) improve the survival of … Hence, this review aims to
describe clinicopathological features… induced by immune checkpoint inhibitors in this review. …